Home › European Commission approves EYLEA Injection for treatment of visual impairment due to DME
 

Keywords :   


European Commission approves EYLEA Injection for treatment of visual impairment due to DME

2014-08-11 12:16:33| Biotech - Topix.net

Regeneron Pharmaceuticals, Inc. today announced that EYLEA Injection has been approved by the European Commission for the treatment of visual impairment due to Diabetic Macular Edema .

Tags: to due treatment visual

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 9
05.11Tropical Storm Rafael Wind Speed Probabilities Number 9
05.11Tropical Storm Rafael Public Advisory Number 9
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 9
05.11Delayed implementation of EID eartag rule requested
More »